Alterations in stool flora resulting from oral kanamycin prophylaxis of necrotizing enterocolitis.
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004352:Drug Resistance, Microbial; D004761:Enterocolitis, Pseudomembranous / Q000517:prevention & control*; D004926:Escherichia coli / Q000187:drug effects; D005243:Feces / Q000382:microbiology*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007612:Kanamycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008297:Male; D012306:Risk
D007612:Kanamycin